Trial intelligence / Profile preview

UC-MSC in Sub-Acute Spinal Cord Injury

NCT03521336Phase 2Unknown

Sponsor
The Third Affiliated Hospital of Sun Yat-sen University
Start
Sep 2019
Primary completion
Dec 2021
Countries
1
01

Overview

A Phase 2 trial of human umbilical cord mesenchymal stem cells in spinal cord injury (SCI), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.

02

Drugs

human umbilical cord mesenchymal stem cells
03

Conditions

spinal cord injury (SCI)

Beyond the preview

Go deeper on NCT03521336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03521336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call